Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Radiotherapy × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 187 Central Nervous System Neoplasms 114 Brain Neoplasms 97 Gliosarcoma 80 Glioma 60 Astrocytoma 59 Oligodendroglioma 32 Neuroblastoma 24 Neoplasm Metastasis 18 Medulloblastoma 18 Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 11 Breast Neoplasms 11 Diffuse Intrinsic Pontine Glioma 10 Ependymoma 9 Meningeal Carcinomatosis 8 Neoplasms 7 Lymphoma 7 Neuroectodermal Tumors, Primitive 6 Lymphoma, Follicular 6 Burkitt Lymphoma 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Recurrence 5 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Optic Nerve Glioma 5 Lymphoma, Large B-Cell, Diffuse 5 Esthesioneuroblastoma, Olfactory 5 Dendritic Cell Sarcoma, Interdigitating 5

Interventions

ziprasidone 1 perampanel 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Temozolomide 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nitrous Oxide 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Memantine 1 Magnetoencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡